Literature DB >> 334132

Short-term dose response characteristics of acetazolamide in man.

B R Friedland, J Mallonee, D R Anderson.   

Abstract

Nine patients with ocular hypertension each randomly received on separate days 0, 63, 125, 250, and 500 mg of acetazolamide (Diamox). In a double masked manner, acetazolamide plasma levels and intraocular pressure were monitored for seven hours following administration. Plasma levels increased linearly with dose, reaching 30 microgram/ml with the 500-mg dose. Maximum plasma levels occurred at one hour, and the minimum IOP was at two hours. The maximum IOP effect was a 30% to 35% fall. The IOP response was related to dose and plasma level, up to a 63-mg dose, which produced an average fall of 8.2 mm Hg. Little further average effect was documented at higher doses or plasma levels. The duration of response was slightly prolonged by 250 mg, but 500 mg showed no greater response. Thus, a 63-mg dose or a plasma level of 4 to 5 microgram/ml was as effective in lowering IOP as higher doses that produced plasma levels of 10 microgram/ml or more.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 334132     DOI: 10.1001/archopht.1977.04450100111014

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  Comparison of the effect of acetazolamide tablets and sustets on diurnal intraocular pressure in patients with chronic simple glaucoma.

Authors:  P W Joyce; K B Mills
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

Review 2.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

3.  Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Nd-YAG laser posterior capsulotomy.

Authors:  I D Ladas; G P Pavlopoulos; S N Kokolakis; G P Theodossiadis
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

4.  Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics.

Authors:  Lizette Warner; James F Glockner; John Woollard; Stephen C Textor; Juan Carlos Romero; Lilach O Lerman
Journal:  Invest Radiol       Date:  2011-01       Impact factor: 6.016

5.  Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study.

Authors:  Lori M Ventura; Vittorio Porciatti
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

6.  Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans.

Authors:  C A McCannel; S R Heinrich; R F Brubaker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 7.  Recent perspectives in ocular drug delivery.

Authors:  Ripal Gaudana; J Jwala; Sai H S Boddu; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

8.  Intraocular and intracranial pressure in glaucoma patients taking acetazolamide.

Authors:  Allison R Loiselle; Emile de Kleine; Pim van Dijk; Nomdo M Jansonius
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.